Anand Divakaran (@adivkrn) profile picture

🇮🇳🇺🇸👨‍🔬 Applying medicinal chemistry & chemical biology to study epigenetics @DanNomura lab. 🎓PhD @UMN_MedChem. 🦮 Former CanDoCanines puppy raiser

Berkeley, CA
Joined February 2017
Photo by Anand Divakaran (@adivkrn)Photo by Anand Divakaran (@adivkrn)Photo by Anand Divakaran (@adivkrn)Photo by Anand Divakaran (@adivkrn)Photo by Anand Divakaran (@adivkrn)Photo by Anand Divakaran (@adivkrn)Photo by Anand Divakaran (@adivkrn)Photo by Anand Divakaran (@adivkrn)Photo by Anand Divakaran (@adivkrn)Photo by Anand Divakaran (@adivkrn)
Anand Divakaran retweeted
TP53: - Discovered 45 years ago, most cited gene all time - No therapies - 500 million people currently living will die of TP53 mutant cancers without new therapies Our Preprint: - A general strategy for TP53 missense mutant cancers (majority) with prototype small molecules
44
272
55
1,322
392,295
Anand Divakaran retweeted
The new class of HHMI investigators average 3.9 papers as corresponding author in Cell, Nature, or Science. 26 out of 26 members of this group previously trained with a PI who is in the National Academy of Sciences or who was an HHMI investigator themselves.
23
179
54
992
348,701
Anand Divakaran retweeted
Congrats to our postdocs Seong Ho (Johnny) Hong & @adivkrn on the discovery of a covalent recruiter against the CUL1 substrate adaptor protein SKP1 that targets a SKP1/substrate receptor interfacing C160 to enable PROTAC applications! @UCB_Chemistry @berkeleyMCB @TheMarkFdn pubs.acs.org/doi/10.1021/acs…
5
12
1
90
10,313
Anand Divakaran retweeted
New @biorxivpreprint from our lab by @Qian37774492 on a covalent 14-3-3 molecular glue with the transcription factors YAP and TAZ and using this glue as a 14-3-3 recruiter to sequester nuclear neo-substrates into the cytosol! Thanks to #AppleTreePartners & @themarkfdn biorxiv.org/content/10.1101/…
2
28
1
119
26,826
Anand Divakaran retweeted
Back and recovered from a stimulating Bioorganic GRC Taking back a lot of new ideas and wonderful memories from catching up with lab alumni, old friends and new. with @adivkrn @ColeScholtz @norvailine @rche54 @EmilyDykhuizen Thanks @DanNomura!
1
19
1,466
Exciting news that missed Twitter last week: I finally had chapter 1 of my dissertation published as a review article on domain-selective BET inhibitors. Thanks @fewill26 and @DanHarki for the many edits on this monster! onlinelibrary.wiley.com/doi/…
1
5
24
2,112
Our Monday morning gift to the TPD community...If you missed @DanNomura's seminar last week this is now available on our @YouTube channel: youtu.be/0V5M76FFbYw
6
39
3,947
Anand Divakaran retweeted
Congrats to @NafsikaForte for the publication of her paper in ACS Chemical Biology on the discovery of a covalent E2 ubiquitin conjugating enzyme UBE2D recruiter for PROTAC applications! Thanks to @NovartisScience. And thanks to @TheMarkFdn ! pubs.acs.org/doi/10.1021/acs…
22
2
93
10,699
Anand Divakaran retweeted
Grateful to see our work highlighted alongside leaders in the field @craigmcrews @IngridWertz @ChoudharyLab @SchreiberStuart in the exciting and exploding area of proximity-inducing modalities for drug discovery in @NatRevDrugDisc nature.com/articles/d41573-0…
28
2
139
14,347
Anand Divakaran retweeted
Proud to see @FrontierMeds announce FMC-376, a covalent inhibitor that directly, rapidly, and completely blocks both active and inactive forms of KRAS G12C to overcome non-response and resistance seen with prior generation KRAS G12C inhibitors! Yay!! globenewswire.com/news-relea…
3
16
1
72
13,276
Rational Chemical Design of Molecular Glue Degraders dlvr.it/ScG912
12
68
Anand Divakaran retweeted
I'm so excited to have this work coming out on our rational design of molecular glue degraders! We converted a number of inhibitors into glues with a simple covalent handle. Such a great project working alongside my good buddy @EthanToriki and under the guidance of @DanNomura!
1
3
22